Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Mig

-- Small-Molecule Program Includes Commercial Opportunities For the Treatment and Prevention of Migraine -- -- Strengthens Allergan's Pipeline of Innovative CNS Development Products -- -- Helps Posi...